Immune Response, Trinity Medical Group deal

The companies will develop IMNR's Salk Immunogen in Thailand.

Trinity will fund drug development in Thailand, in which the companies are proposing to test the immunogen in up to 10,000 HIV-infected individuals. In return, Trinity receives exclusive right to the product in Thailand, Burma, Indonesia, Cambodia, Singapore, Vietnam, Sri Lanka, Malaysia, Laos and the Philippines. ...